Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA clears Artemis' image-guided breast biopsy device:

This article was originally published in Clinica

Executive Summary

Artemis Medical has received US FDA 510(k) clearance for its MiniTome breast biopsy system. The device can localise and immobilise target breast tissue more precisely than current techniques, Artemis claims. It can also accurately cut and remove a large, architecturally intact sample through a minimally invasive incision. An intact sample provides a more definitive diagnosis, explains the Hayward, California firm. Around 1.4 million breast biopsies are performed in the US annually, over 50% of which use open surgical techniques in order to acquire a large intact sample, notes the company.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts